Inari Medical downgraded to Hold from Buy at Deutsche Bank

Deutsche Bank downgraded Inari Medical (NARI) to Hold from Buy with a price target of $80, up from $68. after Stryker (SYK) entered into a definitive agreement to acquire Inari Medical for $4.9B in cash. The deal is expected to close by end of Q1 and given the “highly complementary” nature of Inari’s portfolio, regulatory approvals should be expeditious, the analyst tells investors in a research note.